<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33055181</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-660X</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>17</Day></PubDate></JournalIssue><Title>Journal of clinical microbiology</Title><ISOAbbreviation>J Clin Microbiol</ISOAbbreviation></Journal><ArticleTitle>Positive Impact of Routine Testing for Enterovirus and Parechovirus on Length of Hospitalization and Antimicrobial Use among Inpatients &#x2264;6 Months of Age.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e02106-20</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JCM.02106-20</ELocationID><Abstract><AbstractText>Enterovirus (EV) and parechovirus (PeV) are leading viral causes of central nervous system (CNS) infection among hospitalized neonates and young infants, yet testing for PeV is not routinely performed. The goal of our study was to determine how EV and PeV CSF RT-PCR testing impacted the duration of antibiotic use and the length of hospitalization (LOS) in&#x2009;children &#x2264;6&#x2009;months old with suspected CNS infection. This retrospective cohort study at Children's Mercy Kansas City evaluated data from patients&#x2009;&#x2264;6&#x2009;months old for whom routine CSF EV and PeV reverse transcription-PCR (RT-PCR) testing was performed during January 2011 to December 2018. Electronic data were abstracted from the electronic medical record, including demographics, systemic antimicrobial use, imaging data, herpes simplex virus (HSV) testing, and overall hospital charges. Among 1,926 patients, 345 (17.9%) were RT-PCR positive for EV and 172 (8.9%) were positive for PeV. A significantly shorter LOS was observed for patients with EV (51.6&#x2009;h; <i>P</i>&#x2009;&lt;&#x2009;0.001) and PeV (66.3&#x2009;h; <i>P</i>&#x2009;=&#x2009;0.048) compared to patients that tested negative for both viruses (74.1&#x2009;h). Discontinuation of empirical antibiotic therapy following test result availability occurred more frequently for PeV patients (57.8%; <i>P</i>&#x2009;=&#x2009;0.03) and EV patients (65.4%; <i>P</i>&#x2009;&lt;&#x2009;0.001) than RT-PCR-negative patients (48.5%). Routine EV/PeV RT-PCR testing of cerebrospinal fluid (CSF) samples in children impacted care of hospitalized neonates and young infants. Rapid and prompt diagnosis has the potential to reduce antibiotic usage, length of stay, and patient charges.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Brian R</ForeName><Initials>BR</Initials><Identifier Source="ORCID">0000-0002-1337-1105</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Children's Mercy Hospitals, Kansas City, Missouri, USA blee@cmh.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Missouri, Kansas City, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasidharan</LastName><ForeName>Anjana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Children's Hospitals, Kansas City, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Chris J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Children's Mercy Hospitals, Kansas City, Missouri, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Missouri, Kansas City, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvarangan</LastName><ForeName>Rangaraj</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Children's Hospitals, Kansas City, Missouri, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Missouri, Kansas City, Missouri, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Microbiol</MedlineTA><NlmUniqueID>7505564</NlmUniqueID><ISSNLinking>0095-1137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002555" MajorTopicYN="N">Cerebrospinal Fluid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030061" MajorTopicYN="Y">Parechovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antimicrobial stewardship</Keyword><Keyword MajorTopicYN="N">rapid diagnostics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>15</Day><Hour>17</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33055181</ArticleId><ArticleId IdType="pmc">PMC7771463</ArticleId><ArticleId IdType="doi">10.1128/JCM.02106-20</ArticleId><ArticleId IdType="pii">JCM.02106-20</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McGill F, Griffiths MJ, Solomon T. 2017. Viral meningitis: current issues in diagnosis and treatment. Curr Opin Infect Dis 30:248&#x2013;256. doi:10.1097/QCO.0000000000000355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000355</ArticleId><ArticleId IdType="pubmed">28118219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahant S, Hall M, Schondelmeyer AC, Berry JG, Kimberlin DW, Shah SS, Pediatric Research in Inpatient Settings Network, Collaborative Antiviral Study Group. 2019. Neonatal herpes simplex virus infection among Medicaid-enrolled children. Pediatrics 143:e20183233. doi:10.1542/peds.2018-3233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2018-3233</ArticleId><ArticleId IdType="pmc">PMC6565359</ArticleId><ArticleId IdType="pubmed">30923058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramers C, Billman G, Hartin M, Ho S, Sawyer MH. 2000. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 283:2680&#x2013;2685. doi:10.1001/jama.283.20.2680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.20.2680</ArticleId><ArticleId IdType="pubmed">10819951</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi GR, Watson JT, Nix WA, Oberste MS, Gerber SI. 2018. Enterovirus and parechovirus surveillance&#x2014;United States, 2014&#x2013;2016. MMWR Morb Mortal Wkly Rep 67:515&#x2013;518. doi:10.15585/mmwr.mm6718a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6718a2</ArticleId><ArticleId IdType="pmc">PMC5944979</ArticleId><ArticleId IdType="pubmed">29746455</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi GR, Watson JT, Pham H, Nix WA, Oberste MS, Gerber SI. 2015. Enterovirus and human parechovirus surveillance&#x2014;United States, 2009&#x2013;2013. MMWR Morb Mortal Wkly Rep 64:940&#x2013;943. doi:10.15585/mmwr.mm6434a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6434a3</ArticleId><ArticleId IdType="pubmed">26334674</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop KS, Schinkel J, Minnaar RP, Pajkrt D, Spanjerberg L, Kraakman HC, Berkhout B, Zaaijer HL, Beld MG, Wolthers KC. 2006. Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin Infect Dis 42:204&#x2013;210. doi:10.1086/498905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/498905</ArticleId><ArticleId IdType="pubmed">16355330</ArticleId></ArticleIdList></Reference><Reference><Citation>Olijve L, Jennings L, Walls T. 2018. Human parechovirus: an increasingly recognized cause of sepsis-like illness in young infants. Clin Microbiol Rev 31:e00047-17. doi:10.1128/CMR.00047-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00047-17</ArticleId><ArticleId IdType="pmc">PMC5740974</ArticleId><ArticleId IdType="pubmed">29142080</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvarangan R, Nzabi M, Selvaraju SB, Ketter P, Carpenter C, Harrison CJ. 2011. Human parechovirus 3 causing sepsis-like illness in children from midwestern United States. Pediatr Infect Dis J 30:238&#x2013;242. doi:10.1097/INF.0b013e3181fbefc8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3181fbefc8</ArticleId><ArticleId IdType="pubmed">20948454</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton PN, Dale RC, Nissen MD, Crawford N, Elliott E, Macartney K, Khandaker G, Booy R, Jones CA, PAEDS-ACE Investigators. 2016. Parechovirus encephalitis and neurodevelopmental outcomes. Pediatrics 137:e20152848. doi:10.1542/peds.2015-2848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2015-2848</ArticleId><ArticleId IdType="pubmed">26791970</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong EP, Holscher HC, Steggerda SJ, Van Klink JMM, van Elzakker EPM, Lopriore E, Walther FJ, Brus F. 2017. Cerebral imaging and neurodevelopmental outcome after entero- and human parechovirus sepsis in young infants. Eur J Pediatr 176:1595&#x2013;1602. doi:10.1007/s00431-017-2981-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-017-2981-1</ArticleId><ArticleId IdType="pmc">PMC5682858</ArticleId><ArticleId IdType="pubmed">28891004</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton PN, Khandaker G, Khatami A, Teutsch S, Francis S, McMullan BJ, Jones CA. 2018. High prevalence of developmental concern amongst infants at 12 months following hospitalised parechovirus infection. J Paediatr Child Health 54:289&#x2013;295. doi:10.1111/jpc.13728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.13728</ArticleId><ArticleId IdType="pubmed">28960646</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmquist L, Russo CA, Elixhauser A. 2008. Statistical brief #57. Meningitis-related hospitalizations in the United States, 2006. Healthcare Cost and Utilization Project (HCUP) statistical briefs. Agency for Healthcare Research and Quality, Rockville, MD.</Citation><ArticleIdList><ArticleId IdType="pubmed">21735578</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin NG, Iro MA, Sadarangani M, Goldacre R, Pollard AJ, Goldacre MJ. 2016. Hospital admissions for viral meningitis in children in England over five decades: a population-based observational study. Lancet Infect Dis 16:1279&#x2013;1287. doi:10.1016/S1473-3099(16)30201-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(16)30201-8</ArticleId><ArticleId IdType="pubmed">27527749</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulford WS, Buller RS, Arens MQ, Storch GA. 2004. Correlation of cerebrospinal fluid (CSF) cell counts and elevated CSF protein levels with enterovirus reverse transcription-PCR results in pediatric and adult patients. J Clin Microbiol 42:4199&#x2013;4203. doi:10.1128/JCM.42.9.4199-4203.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.42.9.4199-4203.2004</ArticleId><ArticleId IdType="pmc">PMC516328</ArticleId><ArticleId IdType="pubmed">15365011</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraju SB, Nix WA, Oberste MS, Selvarangan R. 2013. Optimization of a combined human parechovirus-enterovirus real-time reverse transcription-PCR assay and evaluation of a new parechovirus 3-specific assay for cerebrospinal fluid specimen testing. J Clin Microbiol 51:452&#x2013;458. doi:10.1128/JCM.01982-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01982-12</ArticleId><ArticleId IdType="pmc">PMC3553926</ArticleId><ArticleId IdType="pubmed">23175256</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewan M, Zorc JJ, Hodinka RL, Shah SS. 2010. Cerebrospinal fluid enterovirus testing in infants 56 days or younger. Arch Pediatr Adolesc Med 164:824&#x2013;830. doi:10.1001/archpediatrics.2010.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpediatrics.2010.153</ArticleId><ArticleId IdType="pubmed">20819964</ArticleId></ArticleIdList></Reference><Reference><Citation>King RL, Lorch SA, Cohen DM, Hodinka RL, Cohn KA, Shah SS. 2007. Routine cerebrospinal fluid enterovirus polymerase chain reaction testing reduces hospitalization and antibiotic use for infants 90 days of age or younger. Pediatrics 120:489&#x2013;496. doi:10.1542/peds.2007-0252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-0252</ArticleId><ArticleId IdType="pubmed">17766520</ArticleId></ArticleIdList></Reference><Reference><Citation>Debiasi RL, Tyler KL. 2004. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev 17:903&#x2013;925. doi:10.1128/CMR.17.4.903-925.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.17.4.903-925.2004</ArticleId><ArticleId IdType="pmc">PMC523566</ArticleId><ArticleId IdType="pubmed">15489354</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton MS, Jackson MA, Abel D. 1999. Clinical utility of polymerase chain reaction testing for enteroviral meningitis. Pediatr Infect Dis J 18:533&#x2013;537. doi:10.1097/00006454-199906000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-199906000-00011</ArticleId><ArticleId IdType="pubmed">10391184</ArticleId></ArticleIdList></Reference><Reference><Citation>Pires FR, Franco A, Gilio AE, Troster EJ. 2017. Comparison of enterovirus detection in cerebrospinal fluid with Bacterial Meningitis Score in children. Einstein (Sao Paulo) 15:167&#x2013;172. doi:10.1590/s1679-45082017ao3880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s1679-45082017ao3880</ArticleId><ArticleId IdType="pmc">PMC5609612</ArticleId><ArticleId IdType="pubmed">28767914</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner PC, Brayley J, Downing HC, Homfray GJ, Doolan G, Paul SP. 2019. Screening for enteroviral meningitis in infants and children-Is it useful in clinical practice? J Med Virol 91:1882&#x2013;1886. doi:10.1002/jmv.25512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25512</ArticleId><ArticleId IdType="pubmed">31180138</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasidharan A, Harrison CJ, Banerjee D, Selvarangan R. 2019. Emergence of parechovirus A4 central nervous system infections among infants in Kansas City, Missouri, USA. J Clin Microbiol 57:e01698-18. doi:10.1128/JCM.01698-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01698-18</ArticleId><ArticleId IdType="pmc">PMC6498030</ArticleId><ArticleId IdType="pubmed">30787144</ArticleId></ArticleIdList></Reference><Reference><Citation>Feudtner C, Feinstein JA, Zhong W, Hall M, Dai D. 2014. Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr 14:199. doi:10.1186/1471-2431-14-199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2431-14-199</ArticleId><ArticleId IdType="pmc">PMC4134331</ArticleId><ArticleId IdType="pubmed">25102958</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarti P, Warren C, Vincent L, Kumar Y. 2018. Outcome of routine cerebrospinal fluid screening for enterovirus and human parechovirus infection among infants with sepsis-like illness or meningitis in Cornwall, UK. Eur J Pediatr 177:1523&#x2013;1529. doi:10.1007/s00431-018-3209-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-018-3209-8</ArticleId><ArticleId IdType="pubmed">30022279</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigrovic LE, Chiang VW. 2000. Cost analysis of enteroviral polymerase chain reaction in infants with fever and cerebrospinal fluid pleocytosis. Arch Pediatr Adolesc Med 154:817&#x2013;821. doi:10.1001/archpedi.154.8.817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.154.8.817</ArticleId><ArticleId IdType="pubmed">10922279</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CC, Willis M, Meagher A, Gieseker KE, Rotbart H, Glode MP. 2002. Impact of rapid polymerase chain reaction results on management of pediatric patients with enteroviral meningitis. Pediatr Infect Dis J 21:283&#x2013;286. doi:10.1097/00006454-200204000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-200204000-00005</ArticleId><ArticleId IdType="pubmed">12075757</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, McLeish N, Kondracka J, McIntyre CL, McWilliam Leitch EC, Templeton K, Simmonds P. 2011. Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in edinburgh: HPeV type 3 identified as the most common picornavirus type. J Med Virol 83:889&#x2013;896. doi:10.1002/jmv.22023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.22023</ArticleId><ArticleId IdType="pubmed">21412796</ArticleId></ArticleIdList></Reference><Reference><Citation>Janes VA, Minnaar R, Koen G, van Eijk H, Dijkman-de Haan K, Pajkrt D, Wolthers KC, Benschop KS. 2014. Presence of human non-polio enterovirus and parechovirus genotypes in an Amsterdam hospital in 2007 to 2011 compared to national and international published surveillance data: a comprehensive review. Euro Surveill 19:20864. doi:10.2807/1560-7917.es2014.19.46.20964.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.es2014.19.46.20964</ArticleId><ArticleId IdType="pubmed">25425513</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano K, Hamada H, Hirose S, Sugiura K, Harada S, Koizumi M, Hara M, Nishijima H, Taira M, Ogura A, Ogawa T, Takanashi JI. 2018. Prevalence and characteristics of human parechovirus and enterovirus infection in febrile infants. Pediatr Int 60:142&#x2013;147. doi:10.1111/ped.13467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.13467</ArticleId><ArticleId IdType="pubmed">29205679</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbach S, Muller A, Drexler JF, Simon A, Drosten C, Eis-Hubinger AM, Panning M. 2015. Prevalence, type and concentration of human enterovirus and parechovirus in cerebrospinal fluid samples of pediatric patients over a 10-year period: a retrospective study. Virol J 12:199. doi:10.1186/s12985-015-0427-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0427-9</ArticleId><ArticleId IdType="pmc">PMC4660665</ArticleId><ArticleId IdType="pubmed">26607060</ArticleId></ArticleIdList></Reference><Reference><Citation>Balas EA, Chapman WW. 2018. Road map for diffusion of innovation in health care. Health Aff (Millwood) 37:198&#x2013;204. doi:10.1377/hlthaff.2017.1155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2017.1155</ArticleId><ArticleId IdType="pubmed">29401030</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnett J, Vasileiou K, Djemil F, Brooks L, Young T. 2011. Understanding innovators' experiences of barriers and facilitators in implementation and diffusion of healthcare service innovations: a qualitative study. BMC Health Serv Res 11:342. doi:10.1186/1472-6963-11-342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-11-342</ArticleId><ArticleId IdType="pmc">PMC3265424</ArticleId><ArticleId IdType="pubmed">22176739</ArticleId></ArticleIdList></Reference><Reference><Citation>Berwick DM. 2003. Disseminating innovations in health care. JAMA 289:1969&#x2013;1975. doi:10.1001/jama.289.15.1969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.289.15.1969</ArticleId><ArticleId IdType="pubmed">12697800</ArticleId></ArticleIdList></Reference><Reference><Citation>Dearing JW, Cox JG. 2018. Diffusion of innovations theory, principles, and practice. Health Aff (Millwood) 37:183&#x2013;190. doi:10.1377/hlthaff.2017.1104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2017.1104</ArticleId><ArticleId IdType="pubmed">29401011</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE. 2012. Knowledge translation of research findings. Implement Sci 7:50. doi:10.1186/1748-5908-7-50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-5908-7-50</ArticleId><ArticleId IdType="pmc">PMC3462671</ArticleId><ArticleId IdType="pubmed">22651257</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>